AN OPEN-LABEL STUDY TO ASSESS SAFETY AND EFFICACY OF SZC IN PAEDIATRIC PATIENTS WITH HYPERKALAEMIA

Registry ID

D9481C00001

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

ASTRAZENECA AB

Start date

2020-02-03

Last update

2019-01-15

Conditions

• HYPERKALEMIA

Related clinical trials

• A PHASE 2, OPEN-LABEL, MULTIPLE DOSE STUDY TO EVALUATE THE PHARMACODYNAMIC EFFECTS, SAFETY AND TOLERABILITY OF PATIROMER FOR ORAL SUSPENSION IN CHILDREN AND ADOLESCENTS 2 TO < 18 YEARS OF AGE WITH CHRONIC KIDNEY DISEASE AND HYPERKALEMIA (EMERALD)

View on source registry